Modern Management of Anthracycline‐Induced Cardiotoxicity in Lymphoma Patients: Low Occurrence of Cardiotoxicity with Comprehensive Assessment and Tailored Substitution by Nonpegylated Liposomal Doxorubicin

BACKGROUND. Anthracyclines (AC) are still undeniable drugs in lymphoma treatment, despite occasionally causing cardiotoxicity. Liposomal AC may reduce cardiotoxicity while retaining clinical efficacy; also, biomarker monitoring during chemotherapy allows early detection of cardiac damage, enabling s...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncologist
Autors principals: Olivieri, Jacopo, Perna, Gian Piero, Bocci, Caterina, Montevecchi, Claudia, Olivieri, Attilio, Leoni, Pietro, Gini, Guido
Format: Artigo
Idioma:Inglês
Publicat: AlphaMed Press 2017
Matèries:
Hematologic Malignancies
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5388379/
https://ncbi.nlm.nih.gov/pubmed/28275118
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0289
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars